Deltibant

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDeltibant
Drug Alias Name地替班特deltibantum德尔替班SepticorBradycor +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBradykinin B2 receptor antagonists
TargetsBradykinin B2 receptor
Therapy Area/IndicationsSystemic Inflammatory Response Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCortech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesCortech
Active IndicationsN/A
Inactive IndicationsSystemic Inflammatory Response Syndrome

Other Information

ATC CodeN/A
Related LinksKEGG